CHMP Extends Review Period for Portola Pharmaceuticals' Ondexxya™ (andexanet alfa) - P&T Community

CHMP Extends Review Period for Portola Pharmaceuticals' Ondexxya™ (andexanet alfa)  P&T Community

SOUTH SAN FRANCISCO, Calif., Dec. 11, 2018 (GLOBE NEWSWIRE) -- Portola Pharmaceuticals, Inc.® (Nasdaq: PTLA) today announced that the Committee ...